Infosys enters deal with Elan Pharmaceuticals
Printer Print Email Email
Bangalore: Infosys Technologies will now design and implement the Research Informatics System (RISE) at Elan Pharmaceuticals, a biotechnology company, to accelerate discovery research using a co-creation engagement model that leverages the IT firms existing intellectual property in this field, reports PTI. RISE will leverage Infosys' Scientific Innovation Solution for knowledge collaboration, novel ways to unlock disparate data spread across in-house research labs and other commercial or public sources which will be presented to scientists in context of their research needs, a company press release said. The co-creationmodel would enable Infosys retain ownership of co-developed IP as part of the implementation.

siliconindia